# PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease

> **NCT07146815** · NA · COMPLETED · sponsor: **Ziekenhuis Oost-Limburg** · enrollment: 157 (actual)

## Conditions studied

- NAFLD (Nonalcoholic Fatty Liver Disease)
- Polycystic Ovarian Syndrome (PCOS)

## Interventions

- **DIAGNOSTIC_TEST:** FibroScan
- **DIAGNOSTIC_TEST:** MRI PDFF

## Key facts

- **NCT ID:** NCT07146815
- **Lead sponsor:** Ziekenhuis Oost-Limburg
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-29
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07146815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07146815, "PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07146815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*